Your browser doesn't support javascript.
loading
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.
Dourthe, Marie Emilie; Yakouben, Karima; David, Audrey; Thouvenin, Sandrine; Chaillou, Delphine; Caillat-Zucman, Sophie; Cuffel, Alexis; Tardy, Cléa; Lainey, Elodie; Caye-Eude, Aurélie; Arfeuille, Chloé; Delaugerre, Constance; Chaix-Baudier, Marie-Laure; Naudin, Jérôme; Auvin, Stéphane; Bergaoui, Karim; Merlat-Guitard, Anne-Isabelle; De Jorna, Romain; Mebarki, Miryam; Dalle, Jean-Hugues; Baruchel, André.
  • Dourthe ME; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Yakouben K; Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, AP-HP and Université Paris Cité, Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France.
  • David A; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Thouvenin S; Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Saint Etienne, Saint Etienne, France.
  • Chaillou D; Department of Pediatric Hematology and Oncology, Centre Hospitalier Universitaire de Saint Etienne, Saint Etienne, France.
  • Caillat-Zucman S; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Cuffel A; Laboratory of Immunology, Hôpital Universitaire Saint Louis, AP-HP and INSERM UMR1149, Université Paris Cité, Paris, France.
  • Tardy C; Laboratory of Immunology, Hôpital Universitaire Saint Louis, AP-HP and INSERM UMR1149, Université Paris Cité, Paris, France.
  • Lainey E; Pharmacy Department, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Caye-Eude A; Laboratory of Hematology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Arfeuille C; Department of Genetics, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Delaugerre C; INSERM U1131, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.
  • Chaix-Baudier ML; Department of Genetics, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Naudin J; INSERM U1131, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.
  • Auvin S; Laboratory of Virology, Hôpital Saint Louis, AP-HP and Université Paris Cité, Paris, France.
  • Bergaoui K; Laboratory of Virology, Hôpital Saint Louis, AP-HP and Université Paris Cité, Paris, France.
  • Merlat-Guitard AI; Pediatric Intensive Care Unit, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • De Jorna R; Neurology Department, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Mebarki M; Radiology Department, Hôpital Universitaire Robert Debré, AP-HP and Université Paris Cité, Paris, France.
  • Dalle JH; Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Baruchel A; Pharmacy Department, Hôpital Saint Louis, AP-HP and Université Paris Cité, Paris, France.
Br J Haematol ; 205(1): 373-377, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38735758
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 Límite: Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 Límite: Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article